the immune system in humans is regulated by the circadian rhythm. Published studies have reported that the time of vaccination is associated with the immune response to vaccine for some pathogens. our study aimed to evaluate the association between time of dose administration of challenge HBV vaccine and seroconversion for anti-HBs in medical students vaccinated at birth who were found to be unprotected at pre-training screening. humoral protection for HBV was assessed in 885 medical students vaccinated during childhood. In total, 359 (41.0%) of them showed anti-HBs titer < 10 UI/mL and received a challenge dose of HBV vaccine followed by post-vaccination screening 30-60 days later. the challenge dose elicited a protective immune response (anti-HBs IgG titer > 10 UI/mL) in 295 (83.8%) individuals. seroconversion was significantly associated with female gender and time of vaccination after controlling for age group and nationality at logistic regression analysis. students who received the booster dose in the morning had a higher response rate than those who received the vaccine in the afternoon (OR 1.93; 95% C.I. 1.047-3.56: p < 0.05). this finding suggests that morning administration of the HBV booster may result in a better immune response in susceptible individuals.

Coppeta, L., Ferrari, C., Verno, G., Somma, G., Trabucco Aurilio, M., Di Giampaolo, L., et al. (2023). Protective Anti-HBs Antibodies and Response to a Booster Dose in Medical Students Vaccinated at Childhood. VACCINES, 11(8) [10.3390/vaccines11081326].

Protective Anti-HBs Antibodies and Response to a Booster Dose in Medical Students Vaccinated at Childhood

Coppeta L.;Ferrari C.;Verno G.;Somma G.;Treglia M.;Magrini A.;Pietroiusti A.;Rizza S.
2023-01-01

Abstract

the immune system in humans is regulated by the circadian rhythm. Published studies have reported that the time of vaccination is associated with the immune response to vaccine for some pathogens. our study aimed to evaluate the association between time of dose administration of challenge HBV vaccine and seroconversion for anti-HBs in medical students vaccinated at birth who were found to be unprotected at pre-training screening. humoral protection for HBV was assessed in 885 medical students vaccinated during childhood. In total, 359 (41.0%) of them showed anti-HBs titer < 10 UI/mL and received a challenge dose of HBV vaccine followed by post-vaccination screening 30-60 days later. the challenge dose elicited a protective immune response (anti-HBs IgG titer > 10 UI/mL) in 295 (83.8%) individuals. seroconversion was significantly associated with female gender and time of vaccination after controlling for age group and nationality at logistic regression analysis. students who received the booster dose in the morning had a higher response rate than those who received the vaccine in the afternoon (OR 1.93; 95% C.I. 1.047-3.56: p < 0.05). this finding suggests that morning administration of the HBV booster may result in a better immune response in susceptible individuals.
2023
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MEDS-25/B - Medicina del lavoro
English
HBV
booster dose
circadian rhythm
immunological memory
medical students
vaccination
Coppeta, L., Ferrari, C., Verno, G., Somma, G., Trabucco Aurilio, M., Di Giampaolo, L., et al. (2023). Protective Anti-HBs Antibodies and Response to a Booster Dose in Medical Students Vaccinated at Childhood. VACCINES, 11(8) [10.3390/vaccines11081326].
Coppeta, L; Ferrari, C; Verno, G; Somma, G; Trabucco Aurilio, M; Di Giampaolo, L; Treglia, M; Magrini, A; Pietroiusti, A; Rizza, S
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
vaccines-11-01326.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 514.67 kB
Formato Adobe PDF
514.67 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/406053
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 4
social impact